company background image
ALPA logo

Alpa Laboratories NSEI:ALPA Stock Report

Last Price

₹90.79

Market Cap

₹1.9b

7D

-1.2%

1Y

31.0%

Updated

24 Jul, 2024

Data

Company Financials

Alpa Laboratories Limited

NSEI:ALPA Stock Report

Market Cap: ₹1.9b

ALPA Stock Overview

Manufactures and sells pharmaceutical finished dosage forms in India.

ALPA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Alpa Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Alpa Laboratories
Historical stock prices
Current Share Price₹90.79
52 Week High₹115.00
52 Week Low₹68.35
Beta0.89
11 Month Change0.91%
3 Month Change-6.01%
1 Year Change31.01%
33 Year Change85.48%
5 Year Change463.91%
Change since IPO64.62%

Recent News & Updates

We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Jun 08
We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Jun 03
Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Recent updates

We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Jun 08
We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Jun 03
Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Dec 14
Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Aug 26
Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Jan 19
Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

Jun 17
Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Feb 23
If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Nov 24
Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Oct 05
Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

May 31
Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Jan 28
With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Shareholder Returns

ALPAIN PharmaceuticalsIN Market
7D-1.2%0.2%-2.0%
1Y31.0%47.9%42.8%

Return vs Industry: ALPA underperformed the Indian Pharmaceuticals industry which returned 47.9% over the past year.

Return vs Market: ALPA underperformed the Indian Market which returned 42.8% over the past year.

Price Volatility

Is ALPA's price volatile compared to industry and market?
ALPA volatility
ALPA Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: ALPA has not had significant price volatility in the past 3 months.

Volatility Over Time: ALPA's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1967318Paresh Chawlawww.alpalabs.in

Alpa Laboratories Limited manufactures and sells pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations.

Alpa Laboratories Limited Fundamentals Summary

How do Alpa Laboratories's earnings and revenue compare to its market cap?
ALPA fundamental statistics
Market cap₹1.87b
Earnings (TTM)₹167.77m
Revenue (TTM)₹1.09b

11.4x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALPA income statement (TTM)
Revenue₹1.09b
Cost of Revenue₹746.04m
Gross Profit₹341.35m
Other Expenses₹173.58m
Earnings₹167.77m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)7.97
Gross Margin31.39%
Net Profit Margin15.43%
Debt/Equity Ratio3.5%

How did ALPA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.